Active ingredient

Registrations named Ciprofloxacin

Ciprofloxacin is an active ingredient, not a brand name. 10 registrations in the DRAP register carry it in the product name, and the price index attributes them to 1 manufacturer — these are generic products, not one company's range.

Registrations
10
Manufacturers
1
Dosage forms
Injection · Tablet · Infusion
Approved price range
Rs 228.77 – Rs 378.35

Registrations

Registered nameReg. No.StrengthFormManufacturerPrice from
Ciprofloxacin 100mg/50ml Injection045736100mg/50mlInjection——
Ciprofloxacin 200mg/100ml Injection045737200mg/100mlInjection——
Ciprofloxacin 250mg Tablet045739250mgTablet——
Ciprofloxacin 250mg Tablet117795250mgTablet——
Ciprofloxacin 250mg Tablets057488250mgTabletBatala PharmaceuticalsRs 228.77
Ciprofloxacin 500mg Tablet045740500mgTablet——
Ciprofloxacin 500mg Tablet117796500mgTablet——
Ciprofloxacin 500mg Tablets057489500mgTabletBatala PharmaceuticalsRs 378.35
Ciprofloxacin Infusion 200mg/100ml097356D200mg/100mlInfusion——
Ciprofloxacin Tablet 250mg016168-EX250mgTablet——

Why this is not described as a brand

The DRAP register has no separate brand column, so an ingredient name and a trade name look identical in the data. This group is an ingredient: the products below are made by different companies under their own trade names, and no single company owns the word.

How these are grouped

These registrations are grouped by the words in their registered name. Strength, pack size, dosage form and trailing variant words such as Forte, Extra, CF, DS and XR are removed before grouping, so Panadol Tablet, Panadol CF Tablet and Panadol Extra Tablet count as one group. Names that only share a first word but mean different things — for example two companies' unrelated products — can still land together; the registered name of every row is shown so the grouping is checkable.

Source: the bundled DRAP registered-products index and the DRAP price index. Prices are regulatory listings, not pharmacy stock or a retail quote.